Hair treatment composition with naturally - derived peptide identical to human hair
View Patent ↗A hair treatment composition that contains at least one peptide identical to human hair is provided. The peptide is preferably synthesized from naturally-derived amino acids and can serve as a natural alternative to the commonly used human or animal derived (wool) keratin peptides.
1. A treatment composition comprising:
a mixture of a plurality of synthetic peptides created by solid phase peptide synthesis, wherein the plurality of synthetic peptides comprises a first synthetic peptide and a second synthetic peptide, and wherein each of the first peptide and the second peptide consist of the amino acid sequence selected from the group consisting of CRSYR (SEQ ID NO: 1); CGVTR (SEQ ID NO: 2); CGSSRSVR (SEQ ID NO: 3); CAPCQPR (SEQ ID NO: 4); CGGLSYSTTPGR (SEQ ID NO: 5); RSGGVC (SEQ ID NO: 7); CVPCPGGR (SEQ ID NO: 9); CLPAASC (SEQ D NO: 11); RSFSAC (SEQ ID NO: 12); and CLPALC (SEQ ID NO: 13), and wherein each of the first peptide and the second peptide has a terminal protecting group attached thereto.
2. The treatment composition of claim 1 , wherein the plurality of synthetic peptides are each present in molecular weight of 500-700 Daltons to allow easy penetration into the hair.
3. A hair preparation, comprising:
a mixture of a plurality of synthetic peptides created by solid phase peptide synthesis, wherein the plurality of synthetic peptides comprises a first synthetic peptide and a second synthetic peptide, and wherein each of the first peptide and the second peptide consist of the amino acid sequence selected from the group consisting of: CRSYR (SEQ ID NO: 1); CGVTR (SEQ ID NO: 2); CGSSRSVR (SEQ ID NO: 3); CAPCQPR (SEQ ID NO: 4); CGGLSYSTTPGR (SEQ ID NO: 5); RSGGVC (SEQ ID NO: 7); CVPCPGGR (SEQ ID NO: 9); CLPAASC (SEQ D NO: 11); RSFSAC (SEQ ID NO: 12); and CLPALC (SEQ ID NO: 13), and wherein each of the first peptide and the second peptide has a terminal protecting group attached thereto; and cationic conditioners non-ion conditioners, or a combination of the two; and film formers.
4. A hair preparation, comprising:
a mixture of a plurality of synthetic peptides created by solid phase peptide synthesis, wherein the plurality of synthetic peptides comprises a first synthetic peptide and a second synthetic peptide, and wherein each of the first peptide and the second peptide consist of the amino acid sequence selected from the group consisting of: CRSYR (SEQ ID NO: 1); CGVTR (SEQ ID NO: 2); CGSSRSVR (SEQ ID NO: 3); CAPCQPR (SEQ ID NO: 4); CGGLSYSTTPGR (SEQ ID NO: 5); RSGGVC (SEQ ID NO: 7); CVPCPGGR (SEQ ID NO: 9); CLPAASC (SEQ D NO: 11); RSFSAC (SEQ ID NO: 12); and CLPALC (SEQ ID NO: 13), and wherein each of the first peptide and the second peptide has a terminal protecting group attached thereto; and one or more surfactants.
5. A hair coloring composition, comprising:
a mixture of a plurality of synthetic peptides created by solid phase peptide synthesis, wherein the plurality of synthetic peptides comprises a first synthetic peptide and a second synthetic peptide, and wherein each of the first peptide and the second peptide consist of the amino acid sequence selected from the group consisting of: CRSYR (SEQ ID NO: 1); CGVTR (SEQ ID NO: 2); CGSSRSVR (SEQ ID NO: 3); CAPCQPR (SEQ ID NO: 4); CGGLSYSTTPGR (SEQ ID NO: 5); RSGGVC (SEQ ID NO: 7); CVPCPGGR (SEQ ID NO: 9); CLPAASC (SEQ D NO: 11); RSFSAC (SEQ ID NO: 12); and CLPALC (SEQ ID NO: 13), and wherein each of the first peptide and the second peptide has a terminal protecting group attached thereto; and a carrier medium.
6. A treatment composition, comprising:
a mixture of a plurality of synthetic peptides created by solid phase peptide synthesis, wherein the plurality of synthetic peptides comprises a first synthetic peptide, a second synthetic peptide, a third synthetic peptide and a fourth synthetic peptide, and wherein the first synthetic peptide has a sequence consisting of CLPALC (SEQ ID NO: 13), the second synthetic peptide has a sequence consisting of CRSYR (SEQ ID NO: 1), the third synthetic peptide has a sequence consisting of RSFSAC (SEQ ID NO: 12) and the fourth synthetic peptide has a sequence consisting of CGVTR (SEQ ID NO: 2), wherein each of the first peptide, second peptide, third peptide and fourth peptide has a terminal protecting group attached thereto.